Compare United Airlines Holdings Inc (UAL) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
United Airlines Holdings Inc vs Zoetis Inc — how do they compare? United Airlines Holdings Inc trades at $118.05 (market cap $38.15B), while Zoetis Inc trades at $75.47 (market cap $31.95B). The key difference: United Airlines Holdings Inc is the larger of the two by market cap, and Zoetis Inc pays a 2.78% dividend while United Airlines Holdings Inc pays none. Which is the better fit depends on your goals.
| UAL | ZTS | |
|---|---|---|
Market Cap | $38.15B | $31.95B |
Sector | Industrials | Health |
52-Week High | $136.11 | $156.76 |
52-Week Low | $84.57 | $71.91 |
Enterprise Value | $55.18B | $39.24B |
Dividend Yield | — | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
United Airlines (UAL) trades at $117.68, up 1.97% on the day, with a bullish technical signal and strong analyst support. The company has consistently beaten earnings estimates, with Q2 2026 EPS of $1.99 exceeding expectations. Revenue growth is robust, reaching $59.07B in 2025, and profitability metrics like a 5.56% net income margin and 23.25% ROE reflect operational strength. Recent news highlights labor agreements and resilient travel demand despite fuel cost pressures.
The outlook for UAL is positive, driven by strong travel demand and premium revenue growth, with a consensus price target of $163.75 implying significant upside. Risks include volatile fuel prices and operational disruptions, but the company's guidance for 2026 EPS of $9–$11 and improving cash flow trends support a favorable investment case for growth-oriented investors.
Zoetis (ZTS) trades at $75.33, down 1.61% amid mixed technical signals and ongoing securities litigation. The stock shows strong fundamentals with a 28.03% net margin and 67.75% ROE, supported by consistent revenue growth from $8.1B in 2022 to $9.47B in 2025. Recent earnings beat expectations in Q3 and Q4 2025 but missed in Q1 2026, with Q2 results pending. Analyst consensus remains positive with a $101.43 price target, though technical indicators show neutral momentum near key support at $75.
The outlook for ZTS is cautiously optimistic given robust profitability and analyst support, but significant legal overhangs and recent earnings volatility present near-term risks. Long-term growth in animal health markets offers upside, yet investors should monitor litigation developments and Q2 earnings for directional cues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
